Target intelligence / Profile preview

Tetanus toxin antigen

Molecular classification
Exotoxin, Neurotoxin, Bacterial toxin
01

Overview

Tetanus toxin (TeNT) is a potent neurotoxin and protein antigen produced by the bacterium *Clostridium tetani*. It is responsible for the clinical disease tetanus, characterized by spastic paralysis. The toxin is a heterodimeric protein composed of a light chain (L, ~52.4 kDa) and a heavy chain (H, ~98.3 kDa), linked by a disulfide bond. The light chain is a zinc-dependent endopeptidase that cleaves synaptobrevin/VAMP-2 or cellubrevin, disrupting neurotransmitter release. The heavy chain mediates membrane translocation and neuronal binding. TeNT binds specifically to peripheral motor neuron terminals and undergoes retrograde axonal transport to spinal cord inhibitory interneurons, ultimately blocking inhibitory neurotransmission.

02

Mechanism of action

Cleavage of VAMP/synaptobrevin, blocking inhibitory neurotransmission and causing spastic paralysis.

03

Biological functions

Inhibition of neurotransmitter releaseNeurotoxicityAntigen
04

Disease associations

Tetanus
05

Safety considerations

High toxicityPotential for spastic paralysis

Beyond the preview

Go deeper on Tetanus toxin antigen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tetanus toxin antigen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call